Proshare Advisors LLC

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-08
Total Holdings
2,081
Total Value
44301564608
Accession Number
0001085146-25-002761
Form Type
13F-HR
Manager Name
Proshare Advisors LLC
Data Enrichment
99% identified
2,051 identified30 unidentified

Holdings

2,081 positions
Manager:
Search and click to pin securities to the top
Page 101 of 105
T1 Energy Inc.
Shares:
24270(-23.1%)
Value:
$30.6M(-62.5%)
AbCellera Biologics Inc.
Shares:
13443(-3.9%)
Value:
$30.0M(-26.9%)
Montauk Renewables, Inc.
Shares:
14288(-23.1%)
Value:
$29.9M(-59.6%)
Leslie's, Inc.
Shares:
40159(-26.0%)
Value:
$29.5M(-75.6%)
TELOS CORP
Shares:
11924(-23.1%)
Value:
$28.4M(-46.5%)
scPharmaceuticals Inc.
Shares:
10784(-19.9%)
Value:
$28.4M(-40.5%)
CureVac N.V.
Shares:
10120(-4.8%)
Value:
$28.0M(-22.6%)
ENTRAVISION COMMUNICATIONS CORP
Shares:
13311(-23.1%)
Value:
$28.0M(-31.3%)
TrueCar, Inc.
Shares:
17609(-27.0%)
Value:
$27.8M(-69.1%)
Granite Point Mortgage Trust Inc.
Shares:
10668(-24.8%)
Value:
$27.7M(-29.9%)
Alector, Inc.
Shares:
22221(-18.8%)
Value:
$27.3M(-47.1%)
Nkarta, Inc.
Shares:
14637(-19.8%)
Value:
$26.9M(-40.7%)
AMMO, INC.
Shares:
19419(-23.1%)
Value:
$26.8M(-3.6%)
NEKTAR THERAPEUTICS
Shares:
38646(-23.1%)
Value:
$26.3M(-43.8%)
Orion Properties Inc.
Shares:
12155(-23.1%)
Value:
$26.0M(-55.7%)
C4 Therapeutics, Inc.
Shares:
16223(-20.0%)
Value:
$26.0M(-64.5%)
Holley Inc.
Shares:
10080(-23.1%)
Value:
$25.9M(-34.6%)
Lyell Immunopharma, Inc.
Shares:
47966(-18.0%)
Value:
$25.8M(-31.1%)
Larimar Therapeutics, Inc.
Shares:
11985(-19.4%)
Value:
$25.8M(-55.2%)
Neumora Therapeutics, Inc.
Shares:
25738(-17.9%)
Value:
$25.7M(-92.3%)